Skip to main content
. 2013 Feb;87(3):1631–1648. doi: 10.1128/JVI.02795-12

Table 1.

Characteristics of viRNAs expressed in RVFV-infected mosquito cells; evolution during acute and persistent infection in Aag2 cells

Small-RNA library RVFV RNA segment Time p.i. (h) Reads aligning to RVFV genome
Total reads
Reads with mismatches (%)
No. total (unique) Avg length (nt) Avg quality scorea No. (%):
0 ≥1
Genomic sense Antigenomic sense
Aag-2 L segment Mock infection 21,888 (16,682) 10.63 35.44 7,274 (33.2) 15,624 (71.3) 528 (2.41) 21,360 (97.6)
24 54,195 (53,682) 19.11 36.23 23,308 (43) 31,092 (57.3) 41,911 (77.3) 12,284 (22.6)
48 124,516 (119,998) 18.66 36.53 61,825 (49.6) 63,929 (51.3) 92,358 (74.2) 32,158 (25.8)
72 312,657 (306,790) 23.68 36.67 112,001 (35.8) 201,910 (64.6) 282,132 (90.2) 30,525 (9.8)
Passage 3 609,884 (593,874) 23.01 36.69 336,885 (55.2) 281,208 (46.1) 553,914 (90.8) 55,970 (9.2)
M segment Mock infection 10,352 (9,450) 11.33 34.75 6,625 (64) 4,228 (40.8) 527 (5.1) 9,825 (94.9)
24 355,721 (355,353) 22.77 36.37 190,798 (53.6) 165,063 (46.4) 341,638 (96) 14,083 (4)
48 678,728 (675,733) 21.51 36.6 349,433 (51.5) 330,379 (48.7) 639,250 (94.2) 39,478 (5.8)
72 2,265,853 (2,249,092) 24.34 36.63 1,045,619 (46.1) 1,222,596 (53.9) 2,185,093 (96.4) 80,760 (3.6)
Passage 3 1,469,089 (1,458,095) 24.05 36.58 936,518 (63.7) 535,245 (36.4) 1,408,329 (95.9) 60,760 (4.1)
S segment Mock infection 4,338 (4,139) 11.78 35.08 1,435 (33.1) 2,975 (68.6) 446 (10.3) 3,892 (89.7)
24 472,666 (464,823) 19.61 35.92 56,205 (11,9) 416,499 (88.1) 454,575 (96.2) 18,091 (3.8)
48 1,147,187 (1,136,372) 18.83 36.07 81,385 (7.1) 1,065,959 (92.9) 1,102,611 (96.1) 44,576 (3.9)
72 2,412,216 (2,407,348) 23.12 36.37 164,089 (6.8) 2,248,302 (93.2) 2,340,636 (97) 71,580 (3)
Passage 3 2,828,925 (2,824,469) 22.93 36.5 187,089 (6.6) 2,641,998 (93.4) 2,742,861 (97) 86,064 (3)
U4.4 L segment Mock infection 23,802 (16,542) 10.7 35.22 19,110 (80.3) 7,281 (30.6) 627 (2.6) 23,175 (97.3)
48 153,413 (151,045) 23.2 36.14 73,141 (47.7) 81,092 (52.8) 138,236 (90.1) 15,177 (9.9)
M segment Mock infection 17,856 (14,417) 10.54 34.71 8,646 (48.4) 9,616 (53.8) 579 (3.2) 17,277 (96.8)
48 1,967,446 (1,966,524) 24.95 36.28 1,300,017 (66) 667,784 (33.9) 1,855,337 (94.3) 112,109 (5.7)
S segment Mock infection 6,386 (6,120) 11.48 34.72 1,485 (23.2) 4,955 (77.6) 890 (13.9) 5,496 (86.1)
48 2,114,814 (2,113,941) 25.06 36.1 257,160 (12.1) 1,857,749 (87.8) 2,020,445 (95.5) 94,369 (4.5)
C6/36 L segment Mock infection 17,784 (11,576) 10.6 35.4 13,011 (73.1) 7,515 (42.3) 787 (4.4) 16,997 (95.6)
48 47,428 (44,986) 15.86 32.9 24,092 (50.8) 24,541 (51.7) 30,441 (64.2) 16,987 (35.8)
M segment Mock infection 13,259 (12,627) 10.96 35.1 5,117 (38.6) 8,531 (64.3) 601 (4.5) 12,658 (95.5)
48 198,265 (196,710) 17.28 33.45 133,373 (67.2) 66,138 (33.3) 176,283 (88.9) 21,982 (11.1)
S segment Mock infection 9,343 (9,148) 11.66 35.72 3,064 (32.8) 6,318 (67.6) 882 (9.4) 8,461 (90.6)
48 134,035 (133,678) 17.27 32.99 25,488 (19) 108,613 (81) 118,869 (88.7) 15,166 (11.4)
a

Quality score represents an average of the confidence in each sequenced nucleotide in each viRNA.